INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE
Disclosed herein are dihydroceramide desaturase 1 (Des1) inhibitor compounds and compositions, which are useful in the treatment of diseases, such as metabolic disorders, where inhibition of Des1 is expected to be therapeutic to a patient. Methods of inhibition of Des1 activity in a human or animal subject are also provided.
-
(2019/08/20)
COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
The invention provides a novel class of compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1, 4, 5- trisphosphate 3 -kinase B (ITPKb).
-
Page/Page column 17
(2009/01/23)
More Articles about upstream products of 306934-70-3
